SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-21-251568
Filing Date
2021-08-19
Accepted
2021-08-19 16:35:53
Documents
2
Group Members
THIRD ROCK VENTURES GP IV, L.P.TRV GP IV, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13D d214000dsc13d.htm SC 13D 76422
2 EX-99.1 d214000dex991.htm EX-99.1 5832
  Complete submission text file 0001193125-21-251568.txt   83911
Mailing Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116
Business Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116 617-585-2000
Third Rock Ventures IV, L.P. (Filed by) CIK: 0001688327 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142
Business Address 100 BINNEY ST SUITE 700 CAMBRIDGE MA 02142 (857) 320-4900
Tango Therapeutics, Inc. (Subject) CIK: 0001819133 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92241 | Film No.: 211190497
SIC: 2834 Pharmaceutical Preparations